| 產(chǎn)品名稱 |
Aspergillus terreus Thom |
| 商品貨號 |
B187680 |
| Deposited As |
Aspergillus terreus Thom, anamorph |
| Strain Designations |
Cross 23-69 |
| Application |
Biomedical Research and Development Material |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Type Strain |
no |
| Preceptrol® |
no |
| Comments |
soil and human isolates |
| Medium |
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
|
| Growth Conditions |
Temperature: 27.0°C |
| Name of Depositor |
JW Rippon |
| Chain of Custody |
ATCC <<--JW Rippon<<--M. Swerdlow |
| Isolation |
spinal fluid in meningitis |
| References |
Rippon JW, et al. Aspergillosis: comparative virulence, metabolic rate, growth rate and ubiquinone content of soil and human isolates of Aspergillus terreus. Sabouraudia 12: 157-161, 1974. PubMed: 4850653
|
